Lennox International Other Non-Current Liabilities increased by 1.6% to $275.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 44.4%, from $190.50M to $275.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 13.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $154.40M | $154.80M | $159.00M | $166.50M | $175.80M | $175.80M | $158.90M | $160.80M | $159.90M | $157.60M | $168.20M | $173.70M | $179.90M | $184.40M | $225.00M | $190.50M | $191.90M | $191.30M | $270.70M | $275.00M |
| QoQ Change | — | +0.3% | +2.7% | +4.7% | +5.6% | +0.0% | -9.6% | +1.2% | -0.6% | -1.4% | +6.7% | +3.3% | +3.6% | +2.5% | +22.0% | -15.3% | +0.7% | -0.3% | +41.5% | +1.6% |
| YoY Change | — | — | — | — | +13.9% | +13.6% | -0.1% | -3.4% | -9.0% | -10.4% | +5.9% | +8.0% | +12.5% | +17.0% | +33.8% | +9.7% | +6.7% | +3.7% | +20.3% | +44.4% |